Jupiter Research Capital (Asia) Ltd’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.47M Buy
+15,370
New +$3.26M 0.38% 62
2026
Q1
– Sell
-35,249
Closed -$6.2M – 777
2025
Q4
$6.2M Buy
+35,249
New +$5.76M 1.3% 8

Other funds holding BIIB

Jupiter Research Capital (Asia) Ltd's BIIB Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Biogen (BIIB) in Q3 2026: 15,370 shares worth $3.47M. The stake represents 0.38% of the portfolio and ranks #62 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in BIIB as recently as Q4 2025.

Jupiter Research Capital (Asia) Ltd first reported a position in BIIB in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.2M in Q4 2025. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 15,370 shares of Biogen worth $3.47M as of Q3 2026.
  • Biogen was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Biogen made up 0.38% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #62 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Biogen in Q4 2025 and has held it in 2 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Biogen position peaked at $6.2M in Q4 2025.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.